摘要
骨巨细胞瘤临床上较为常见。其虽为良性肿瘤,却于局部侵袭生长,且可远隔转移,目前治疗效果尚不理想^[1]。改善当前治疗困境,有赖于更为深入地了解其生物学特性,我们将就近年来相关研究的现况进行综述。一。
出处
《中华外科杂志》
CAS
CSCD
北大核心
2012年第5期468-470,共3页
Chinese Journal of Surgery
参考文献35
-
1本刊编辑部,杨子明,郭卫,牛晓辉,黄啸原.骨巨细胞瘤生物学特性及治疗对策高级学术论坛学术讨论纪要[J].中华外科杂志,2006,44(12):793-796. 被引量:9
-
2Ghert M, Simunovic N, Cowan RW, et al. Properties of the stromal cell in giant cell tumor of bone. Clin Orthop Relat Res, 2007, 459: 8-13.
-
3Wulling M, Delling G, Kaiser E. The origin of the neoplastic stromal cell in giant cell tumor of bone. Hum Pathol, 2003, 34 : 983-993.
-
4Nishimura M, Yuasa K, Mori K, et al. Cytological properties of stromal cells derived from giant cell tumor of bone (GCTSC) which can induce osteoclast formation of human blood monocytes without cell to cell contact. J Orthop Res, 2005, 23: 979-987.
-
5Gorunova L, Vult van Steyern F, Storlazzi CT, et al. Cytogenetic analysis of 101 giant cell tumors of bone: nonrandom patterns of telomeric associations and other structural aberrations. Genes Chromosomes Cancer, 2009, 48 : 583-602.
-
6Gebre-Medhin S, Broberg K, Jonson T, et al. Telomeric associations correlate with telomere length reduction and clonal chromosome aberrations in giant cell tumor of bone. Cytogenet Genome Res, 2009, 124 : 121-127.
-
7Moskovszky L, Szuhai K, Krenacs T, et al. Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analysis. Genes Chromosomes Cancer, 2009, 48: 468-479.
-
8Wuelling M, Delling G, Kaiser E. Differential gene expression in stromal cells of human giant cell tumor of bone. Virchows Arch, 2004, 445: 621-630.
-
9Papanastassiou I, Ioannou M, Papagelopoulos PJ, et al. P53 expression as a prognostic marker in giant cell tumor of bone: a pilot study. Orthopedics, 2010, 33:307.
-
10Rao UN, Goodman M, Chung WW, et al. Molecular analysis of primary and recurrent giant cell tumors of bone. Caneer Genet Cytogenet, 2005, 158: 126-136.
共引文献8
-
1桂龙升,彭浩,赵毅,王平.肋骨及胸椎骨巨细胞瘤一例[J].中国综合临床,2009,25(5):558-558.
-
2丁文元,王辉.脊柱骨巨细胞瘤二例报道[J].中国骨与关节杂志,2012,1(3):322-324.
-
3谭桢,赵劲民,程建文.骨巨细胞瘤手术治疗分析[J].广西医学,2013,35(10):1341-1342. 被引量:1
-
4许霖,宦怡.脊柱骨巨细胞瘤的病理及影像学表现[J].医疗卫生装备,2015,36(8):113-115. 被引量:4
-
5郭卫,杨毅.骨巨细胞瘤的外科治疗方法[J].中国骨与关节杂志,2016,5(1):1-3. 被引量:6
-
6许霖,崔博,杜希娜,赵向乾,吕秀花,张彤,杨广夫.胸椎骨巨细胞瘤的影像学表现[J].实用放射学杂志,2016,32(2):247-250. 被引量:4
-
7吴伟斌,彭涛,潘献伟,孟家晓,邹映文,何俊.骨巨细胞瘤影像学特征及误诊分析[J].CT理论与应用研究(中英文),2017,26(4):505-510. 被引量:8
-
8史凌子,邓婕.高位胸椎骨巨细胞瘤一例误诊分析并文献复习[J].延安大学学报(医学科学版),2020,18(4):91-93. 被引量:1
同被引文献18
-
1毕乃贵,王民,王莹.CD147在骨巨细胞瘤中的表达及临床意义[J].现代肿瘤医学,2007,15(12):1846-1848. 被引量:7
-
2Niu X, Zhang Q, Hao L, et al. Giant cell tumor of the extremity : retrospective analysis of 621 Chinese patients from one institution [J:. J Bone Joint Surg Am, 2012, 94(5) :461-467.
-
3Klenke FM, Wenger DE, Inwards CY, et al. Giant cell tumor of bone: risk factors for recurrence [ J :. Clin Orthop Relat Res, 2011, 269(2) : 591-599.
-
4Lan J, Liu X, Rong W, et al. Stro-l(+) stromal cells have stem-like features in giant cell tumor of bone [ J ]. J Surg Oncol, 2012, 106(7) :826-836.
-
5Kreitz S, Fackelmayer FO, Gerdes J, et al. The proliferation- specific human Ki-67 protein is a constituent of compact chromat- in[ J]. Exp Cell Res, 2000, 261 (1) :284-292.
-
6Weigmann A, Corbeil D, Hetlwig A, et al. Prominin-1, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of nonepithelial cells [ J ]. Proc Nat1 Acad Sci USA, 1997, 94 (23) : 12425-12430.
-
7Grosse-Gehling PI, Fargeas CA, Ditffeld C, et al. CD133 as a biomarker for putative cancer stem cells in solid tumours: limita- tions, problems and challenges[ Jl. J Pathol,2013, 229(3) :355 -378.
-
8Oliveira VC, van der Heijden L, van der Geest IC, Giant cell tumours of the small bones of the hands and feet: long-term results of 30 patients and a systematic literature review[ J]. Bone Joint J,2013, 95(6) :838-845.
-
9van der Heijden L, van de Sande MA, Dijkstra PD. Soft tissue extension increases the risk of local recurrence after curettage with adjuvants for giant-cell tumor of the long bones[ J:. Acta Orthop, 2012, 83(4) :401-405.
-
10Errani C, Ruggieri P, Asenzio MA, et al. Giant cell tumor of the extremity : A review of 349 cases from a single institution [ J 1. Cancer Treat Rev,2010, 36(1) :1-7.
引证文献3
-
1米宁,刘婕.CD147、VEGF在骨巨细胞瘤中的表达及临床研究[J].成都医学院学报,2014,9(1):50-53. 被引量:1
-
2刘广飞,王璐,李勇,程才.CD133和Ki-67在骨巨细胞瘤中的表达及其临床意义[J].临床肿瘤学杂志,2015,20(8):690-693. 被引量:3
-
3刘广飞,程才,王璐,李勇.蛋白CD133在骨巨细胞瘤中的表达及临床意义[J].湖南师范大学学报(医学版),2015,12(2):115-117. 被引量:3
二级引证文献7
-
1刘娜.CD133、Ki-67在胃癌的表达及临床病理意义[J].中国医药科学,2015,5(20):157-160. 被引量:1
-
2王保华.骨巨细胞瘤组织中上皮型钙黏蛋白、血管内皮生长因子的表达及临床意义[J].肿瘤基础与临床,2016,29(1):20-22.
-
3陈文祥,樊根涛,赵建宁.肩胛骨骨巨细胞瘤1例[J].临床肿瘤学杂志,2016,21(10):959-960.
-
4岳国阳.骨巨细胞瘤组织中MMP-2、Ki-67的表达及其诊断价值[J].肿瘤基础与临床,2017,30(1):72-73. 被引量:3
-
5曾宪辉.巨骨细胞瘤患者MRI影像特点及病理分析[J].中国CT和MRI杂志,2017,15(8):137-139. 被引量:3
-
6陈秀娇,徐丽,陈智伟,郑伟男.胃癌组织中CD147和VEGF的表达及其临床意义[J].锦州医科大学学报,2018,39(5):1-3. 被引量:3
-
7蒋建召,武俊敏,金海伟.骨巨细胞瘤患者血清NTx、VEGF变化及其与临床病理特征及预后的关系[J].实用癌症杂志,2021,36(5):744-748. 被引量:2